Selected article for: "host cell and viral envelope"

Author: Elste, James; Kaltenbach, Dominik; Patel, Vraj R.; Nguyen, Max T.; Sharthiya, Harsh; Tandon, Ritesh; Mehta, Satish K.; Volin, Michael V.; Fornaro, Michele; Tiwari, Vaibhav; Desai, Umesh R.
Title: Inhibition of Human Cytomegalovirus Entry into Host Cells through A Pleiotropic Small Molecule
  • Document date: 2020_2_29
  • ID: 031ro01b_36
    Snippet: The 2nd major reason for the novelty behind the discovery of SPGG is the possibility of simultaneous engagement of multiple receptors involved in HCMV entry into host cells. Complex interactions between viral envelope glycoproteins and host cell receptors come into play for successful entry [23, 24] . One reason why nature seems to have engineered multiplicity of such interactions is to ensure probability of success. To significantly reduce effic.....
    Document: The 2nd major reason for the novelty behind the discovery of SPGG is the possibility of simultaneous engagement of multiple receptors involved in HCMV entry into host cells. Complex interactions between viral envelope glycoproteins and host cell receptors come into play for successful entry [23, 24] . One reason why nature seems to have engineered multiplicity of such interactions is to ensure probability of success. To significantly reduce efficiency of entry, it is important to simultaneously impact these interactions. Thus, targeting only interactions of 3-O-sulfated or 6-O-sulfated species, inhibition of HCMV entry may not yield a clinically viable agent. Despite being small, SPGG presents a diverse library of sulfated species that could bind all possible heparan sulfate binding receptors, thereby impeding viral recognition. This appears to be the case because SPGG binding to glycoprotein gB explains only part of the inhibition effect. Thus, pleiotropicity of SPGG interactions may be a key reason for its high anti-HCMV potency.

    Search related documents:
    Co phrase search for related documents
    • bind receptor and entry efficiency: 1, 2, 3
    • bind receptor and envelope glycoprotein: 1, 2, 3, 4, 5, 6, 7
    • bind receptor and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • bind receptor and host cell receptor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • bind receptor and inhibition effect: 1
    • case appear and host cell: 1, 2
    • complex interaction and entry efficiency: 1
    • complex interaction and envelope glycoprotein: 1
    • complex interaction and hcmv entry: 1
    • complex interaction and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • complex interaction and host cell receptor: 1, 2, 3, 4, 5, 6
    • diverse library and host cell: 1
    • entry efficiency and envelope glycoprotein: 1, 2
    • entry efficiency and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • entry efficiency and host cell receptor: 1, 2, 3
    • envelope glycoprotein and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • envelope glycoprotein and host cell receptor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • envelope glycoprotein and host cell receptor viral envelope glycoprotein: 1
    • hcmv entry and host cell: 1, 2, 3, 4, 5